文章摘要
重复经颅磁刺激结合正念认知疗法应用于酒精依赖戒断综合征患者的临床研究
Clinical study of repeated transcranial magnetic stimulation combine with mindfulness-based cognitive therapy in patients with alcohol dependence withdrawal syndrome
投稿时间:2025-03-31  修订日期:2025-03-31
DOI:
中文关键词: 重复经颅磁刺激  正念认知疗法  酒精依赖戒断综合征  自我控制能力  焦虑抑郁  复饮率  再住院率
英文关键词: Repetitive transcranial magnetic stimulation  Mindfulness-based cognitive therapy  Alcohol dependence withdrawal syndrome  Self-control ability  Anxiety and depression  Relapse rate  Readmission rate
基金项目:福建省卫健委中青年骨干人才培养项目(2019-ZQNB-33)
作者单位邮编
刘晓铃* 厦门市仙岳医院/厦门市精神卫生中心 361000
摘要点击次数: 20
全文下载次数: 0
中文摘要:
      目的:观察重复经颅磁刺激(rTMS)结合正念认知疗法(MBCT)应用于酒精依赖戒断综合征(AWS)患者的临床疗效。方法:本研究观察的120例AWS患者均为2021年6月至2024年6月我科收治的男性患者,按照随机数字表法将患者分为A组(常规治疗,40例)、B组(A组基础上结合rTMS,40例)、C组(B组基础上结合MBCT,40例)。对比三组临床疗效、自我控制能力[改良临床机构酒精依赖戒断评估表(CIWA-Ar)评分、酒精心理渴求视觉模拟量表(VAS)评分、宾夕法尼亚酒精渴求量表(PACS)评分]、焦虑抑郁程度[汉密尔顿抑郁量表(HAMD)评分、汉密尔顿焦虑量表(HAMA)评分]和生活质量[36项简短健康调查量表(SF-36)评分]、复饮率、再住院率。结果:A组、B组、C组的总有效率依次升高(P<0.05)。B组、C组治疗后的CIWA-Ar、PACS、酒精心理渴求VAS评分低于A组,且C组低于B组(P<0.05)。B组、C组治疗后的HAMD、HAMA评分低于A组,且C组低于B组(P<0.05)。B组、C组治疗后的SF-36评分高于A组,且C组高于B组(P<0.05)。B组、C组的复饮率和再住院率低于A组,且C组低于B组(P<0.05)。结论:rTMS结合MBCT应用于AWS患者,可提高临床疗效和生活质量,减轻焦虑抑郁程度,改善患者的自我控制能力,降低复饮率、再住院率,效果确切。
英文摘要:
      Objective: To observe the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) combine with mindfulness-based cognitive therapy (MBCT) in patients with alcohol dependence withdrawal syndrome (AWS). Methods: The 120 patients with AWS who were observed in this study were all male patients admitted to our department from June 2021 to June 2024, the patients were divided into Group A (conventional treatment, 40 cases), Group B (group A combined with rTMS, 40 cases), and group C (Group B combined with MBCT, 40 cases) according to random number table method. The clinical efficacy, self-control ability [Modified Clinical Institution Alcohol Dependence Withdrawal Assessment Scale (CIWA-Ar) score, Visual Analog Scale of Psychological Craving for Alcohol (VAS) score and Pennsylvania Alcohol Craving Scale (PACS) score], anxiety and depression degree assessment [Hamilton Depression Scale (HAMD) score, Hamilton Anxiety Scale (HAMA) score] and quality of life assessment [36 Short Form Health Survey (SF-36) Score], relapse rate and readmission rate were compared among the three groups. Results: The total effective rate of group A, group B and group C increased successively (P<0.05). The CIWA-Ar, PACS and VAS scores in group B and group C after treatment were lower than those in group A, and group C was lower than that in group B (P<0.05). The HAMD and HAMA scores of group B and group C after treatment were lower than those in group A, and group C was lower than that in group B (P<0.05). The SF-36 score of group B and group C after treatment was higher than those in group A, and group C was higher than that in group B (P<0.05). Relapse rate and readmission rate in groups B and C were lower than those in group A, and group C was lower than that in group B (P<0.05). Conclusion: The application of rTMS combine with MBCT in AWS patients can improve clinical efficacy and quality of life, alleviate anxiety and depression, improve patients'' self-control ability, reduce relapse rate and readmission rate, with definite effects.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭